ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword?

Am J Respir Crit Care Med. 2020 Sep 1;202(5):777-778. doi: 10.1164/rccm.201912-2460LE.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Centers for Disease Control and Prevention, U.S.
  • Humans
  • Tuberculosis, Multidrug-Resistant* / drug therapy
  • United States

Substances

  • Antitubercular Agents